Muscle loss linked to worse surgery outcomes in colorectal cancer patients
NCT ID NCT06698289
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 70 adults with colorectal cancer to see how common muscle loss (sarcopenia) is before surgery and whether it leads to more complications or longer hospital stays. Researchers measured muscle strength, mass, and physical performance. The goal is to find patients who might benefit from extra support before surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
70 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This prospective observational study will be conducted at the Department of General Surgery, Mersin University Hospital, between November 15, 2024, and November 15, 2025. The study population consists of adult patients (≥18 years) diagnosed with colorectal cancer who are scheduled for surgical intervention. Patients will be categorized into sarcopenia and non-sarcopenia groups based on EWGSOP criteria, incorporating muscle strength, muscle mass, and physical performance measurements.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Having a diagnosis of colon cancer * Having undergone surgery at Mersin University General Surgery Department as of 15.11.2024 * Patients aged 18 years and above * Patients whose descriptive and clinical characteristics are recorded in their medical files * Those who have signed the Informed Volunteer Consent Form/Written Consent Form Exclusion Criteria: * Patients under 18 years of age * Patients whose descriptive and clinical characteristics are not recorded in the file records * Those who did not sign the Informed Volunteer Form/Written Consent Form
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colon cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mersin University
Mersin, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a robotic exoskeleton rebuild aging legs?
- Immunotherapy added to standard treatment aims to save the anus in Ultra-Low rectal cancer
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Can a personalized menu keep cancer patients stronger through chemotherapy?
- Can surgeons spare nerves and still cure colon cancer?